CLL-1 (C-type lectin-like molecule 1) is a protein selectively present on leukemia stem cells in acute myeloid leukemia (AML) and absent in normal hematopoietic stem cells, making it an exceptional therapeutic target [56]. The gene discussed is CLEC12A; the disease is leukemia.